Industry Partners
Request for Information for Investigational Products for the Military and Veterans PTSD Adaptive Platform Clinical Trial (M‑PACT)
The Defense Health Agency-funded PTSD Drug Treatment Program is seeking information, on a rolling basis, for investigational drug therapies to test as part of M‑PACT.
We encourage responses from potential industry partners about investigational products for consideration for inclusion in the M‑PACT study.
The following selection criteria will be taken into consideration:
- Phase 2 or Phase 3 “ready” (availability of compound and placebo, previous human trial experience)
- Suitability for military populations and/or for military settings based on safety profile, dosing schedule, portability of doses, stability profile, etc.
The following selection criteria will be taken into consideration:
- Phase 2 or Phase 3 “ready” (availability of compound and placebo, previous human trial experience)
- Suitability for military populations and/or for military settings based on safety profile, dosing schedule, portability of doses, stability profile, etc.
